Beneficiaries
Our 9 Beneficiaries (B) from 6 different countries employ the 14 Early Stage Researchers (PhDs) for 3 years each. They closely collaborate to provide a highly multidisciplinary and intersectoral training and research scheme.
B1: National Hellenic Research Foundation, Greece
Institute of Biology, Medicinal Chemistry and Biotechnology Scientist-in-Charge: Dr. Theodora Calogeropoulou |
B2: HITS gGmbH, Heidelberg Institute for Theoretical Studies, Germany
Molecular and Cellular Modeling Group Scientist-in-Charge: Prof. Rebecca Wade |
B3: University of Siena, Italy
Department of Biotechnology, Chemistry and Pharmacy Scientist-in-Charge: Prof. Stefano Mangani |
B4: Université de Caen Normandie, France
UFR des Sciences Pharmaceutiques, Centre d'Etudes et de Recherche sur le médicament de Normandie Scientist-in-Charge: Prof. Christophe Rochais |
B5: National and Kapodistrian University of Athens, Greece
Faculty of Pharmacy, Department of Pharmacognosy and Chemistry of Natural Products Scientist-in-Charge: Prof. Vassilios Roussis |
B6: Technische Universität Dresden, Germany
Faculty of Medicine, Department of Clinical Pathobiochemistry Scientist-in-Charge: Dr. Alexaki Vasileia Ismini |
B8: Foundation for Research and Technology Hellas, Greece
Institute of Molecular Biology and Biotechnology Scientist-in-Charge: Prof. Achilleas Gravanis |
B9: University of Sheffield, United Kingdom
Sheffield Institute for Translational Neuroscience Scientist-in-Charge: Prof. Dame Pamela Shaw |
B10: VU University of Amsterdam, Netherlands
Department of Molecular and Cellular Neurobiology Scientist-in-Charge: Ass. Prof. Ka Wan Li |